Details for New Drug Application (NDA): 071909
✉ Email this page to a colleague
NDA 071909 describes SODIUM IODIDE I 123, which is a drug marketed by Cardinal Health 418, Curium, and Ge Healthcare, and is included in four NDAs. It is available from two suppliers. Additional details are available on the SODIUM IODIDE I 123 profile page.
The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
Summary for 071909
| Tradename: | SODIUM IODIDE I 123 |
| Applicant: | Curium |
| Ingredient: | sodium iodide i-123 |
| Patents: | 0 |
Suppliers and Packaging for NDA: 071909
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 071909 | ANDA | Curium US LLC | 69945-601 | 69945-601-10 | 1 BOTTLE in 1 CAN (69945-601-10) / 1 CAPSULE, GELATIN COATED in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100uCi | ||||
| Approval Date: | Feb 28, 1989 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
